BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 18662521)

  • 1. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 2. [Is statin treatment for children safe and effective?].
    Marchetti F; Cannioto Z
    Recenti Prog Med; 2008 Dec; 99(12):599-601. PubMed ID: 19388217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based guidelines for cardiovascular risk reduction: the safety and efficacy of high-dose statin therapy.
    Ashen MD; Foody JM
    J Cardiovasc Nurs; 2009; 24(6):429-38. PubMed ID: 19786883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lowering cholesterol: how low is low enough?].
    Czuriga I; Edes I
    Orv Hetil; 2006 Jul; 147(29):1349-56. PubMed ID: 16941825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin therapy in the elderly: a review.
    Szadkowska I; Stanczyk A; Aronow WS; Kowalski J; Pawlicki L; Ahmed A; Banach M
    Arch Gerontol Geriatr; 2010; 50(1):114-8. PubMed ID: 19217673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growing body of evidence shows benefits of aggressive lipid management in high-risk patients.
    Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():3, 5. PubMed ID: 12608151
    [No Abstract]   [Full Text] [Related]  

  • 7. Stricter cholesterol guidelines broaden indications for the 'statin' drugs.
    Capriotti T
    Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
    MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased statin dose could mean a 22% decrease in vascular events. Even patients with low baseline LDL can benefit from increased doses.
    Duke Med Health News; 2011 Jan; 17(1):3. PubMed ID: 21313727
    [No Abstract]   [Full Text] [Related]  

  • 10. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy.
    Wiviott SD; Cannon CP
    Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
    Barter PJ; Rye KA
    Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953
    [No Abstract]   [Full Text] [Related]  

  • 12. [Statin and absorption inhibitor work synergistically. More risk patient reach LDL cholesterol goal value].
    MMW Fortschr Med; 2007 Apr; 149(17):56-7. PubMed ID: 17674912
    [No Abstract]   [Full Text] [Related]  

  • 13. Statin effects in CKD: is there a "point of no return"?
    Wanner C
    Am J Kidney Dis; 2009 May; 53(5):723-5. PubMed ID: 19393469
    [No Abstract]   [Full Text] [Related]  

  • 14. Are we lowering LDL cholesterol sufficiently?
    Barter P; Rye KA
    Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988
    [No Abstract]   [Full Text] [Related]  

  • 15. Ask the doctor. Taking a cholesterol-lowering statin has brought down my bad cholesterol (LDL) to only 37 mg/dL. My liver and muscles are fine. The very low LDL worries my doctor. Should I change my regimen?
    Lee TH
    Harv Heart Lett; 2002 Oct; 13(2):8. PubMed ID: 12393347
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ezetimib as combination partner in hypercholesteremia. Lowering LDL beyond the effect of statins].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 Apr; 145(16):48-50. PubMed ID: 14606402
    [No Abstract]   [Full Text] [Related]  

  • 17. [Strengthened support for statin therapy as secondary prevention. Doubtful evidence for more intensive lowering of cholesterol levels].
    HÃ¥kansson J
    Lakartidningen; 2011 Jun 1-14; 108(22-23):1234-5. PubMed ID: 21786497
    [No Abstract]   [Full Text] [Related]  

  • 18. [Target levels for LDL cholesterol are put out of the running. Cholesterol should be lowered maximally in high cardiovascular risk].
    Olsson AG
    Lakartidningen; 2011 Jun 1-14; 108(22-23):1240-3. PubMed ID: 21786498
    [No Abstract]   [Full Text] [Related]  

  • 19. The primary target. Taking aim at LDL levels to prevent cardiovascular disease.
    Mason CM
    Adv Nurse Pract; 2007 Dec; 15(12):55-8. PubMed ID: 20014676
    [No Abstract]   [Full Text] [Related]  

  • 20. Does aggressive statin therapy offer improved cholesterol-independent benefits compared to conventional statin treatment?
    Gupta S
    Int J Cardiol; 2004 Aug; 96(2):131-9. PubMed ID: 15262025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.